• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Marinus Pharmaceuticals

edit

Marinus is a specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of novel drugs to treat serious neurological, psychiatric, and pain disorders. The Company’s lead product is a first in class therapy for epilepsy. Marinus Pharmaceutica’s investors include Domain Associates, Canaan Partners, Sofinnova Ventures and Foundation Medical Partners. The Company is located in Branford, Connecticut.

Milestones

edit

• 
  Marinus Pharmaceuticals received $20M in Series B funding. (5/3/09)
  Posted 6/24/09 at 1:40pm via onbiovc.com

Videos

Screenshots

edit

Sources

1. Marinus Pharmaceuticals, Inc.: Series B $20M (onbiovc.com) [edit]